5-Fluorouracil-induced death of Jurkat T-cells - A role for caspases and MCL-1

Anticancer Research

Volumn 30, Issue 10, 2010, Pages 3879-3887

  Aresvik, Dina M ^a   Pettersen, Rolf D ^b   Abrahamsen, Tore G ^c   Wright, Marianne S ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

5 fluorouracil; Apoptosis; Jurkat; MCL 1; T cells

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE; CASPASE 3; CASPASE INHIBITOR; DIMETHYL SULFOXIDE; FLUOROURACIL; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN MCL 1; REACTIVE OXYGEN METABOLITE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVATION; FLOW CYTOMETRY; LEUKEMIA CELL; LEUKEMIA CELL LINE; MUTATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION;

AMINO ACID CHLOROMETHYL KETONES; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; CASPASE 3; CELL DEATH; CYSTEINE PROTEINASE INHIBITORS; ENZYME ACTIVATION; FLUOROURACIL; HUMANS; JURKAT CELLS; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-BCL-2; T-LYMPHOCYTES;

EID: 78650237490     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Cory S and Adams JM: The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2: 647-656, 2002.
2. Degterev A and Yuan J: Expansion and evolution of cell death programmes. Nat Rev Mol Cell Biol 9: 378-390, 2008.
3. Danial NN and Korsmeyer SJ: Cell death: critical control points. Cell 116: 205-219, 2004.
4. Lavrik IN, Golks A and Krammer PH: Caspases: pharmacological manipulation of cell death. J Clin Invest 115: 2665-2672, 2005.
5. Riedl SJ and Shi Y: Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 5: 897-907, 2004.
6. Youle RJ and Strasser A: The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9: 47-59, 2008.
7. Chipuk JE and Green DR: Dissecting p53-dependent apoptosis. Cell Death Differ 13: 994-1002, 2006.
8. Green DR and Kroemer G: Pharmacological manipulation of cell death: clinical applications in sight? J Clin Invest 115: 2610-2617, 2005.
9. Ow YP, Green DR, Hao Z and Mak TW: Cytochrome c: functions beyond respiration. Nat Rev Mol Cell Biol 9: 532-542, 2008.
10. Kroemer G, Galluzzi L and Brenner C: Mitochondrial membrane permeabilization in cell death. Physiol Rev 87: 99-163, 2007. (Pubitemid 46209992)
11. Chipuk JE and Green DR: How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol 18: 157-164, 2008.
12. Roos WP and Kaina B: DNA damage-induced cell death by apoptosis. Trends Mol Med 12: 440-450, 2006.
13. Vousden KH and Lane DP: p53 in health and disease. Nat Rev Mol Cell Biol 8: 275-283, 2007.
14. Michalak E, Villunger A, Erlacher M and Strasser A: Death squads enlisted by the tumour suppressor p53. Biochem Biophys Res Comm 331: 786-798, 2005.
15. Longley DB, Harkin DP and Johnston PG: 5-Fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 3: 330-338, 2003.
16. Cheng J and Haas M: Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines. Mol Cell Biol 10: 5502-5509, 1990.
17. Bode AM and Dong Z: Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer 4: 793-805, 2004.
18. Bassett EA, Wang W, Rastinejad F and El-Deiry WS: Structural and functional basis for therapeutic modulation of p53 signaling. Clin Cancer Res 14: 6376-6386, 2008.
19. Green DR and Kroemer G: Cytoplasmic functions of the tumour suppressor p53. Nature 458: 1127-1130, 2009.
20. Soussi T and Beroud C: Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer 1: 233-240, 2001.
21. Strano S, Dell'Orso S, Di AS, Fontemaggi G, Sacchi A and Blandino G: Mutant p53: an oncogenic transcription factor. Oncogene 26: 2212-2219, 2007.
22. Peller S and Rotter V: TP53 in hematological cancer: low incidence of mutations with significant clinical relevance. Human Mutation 21: 277-284, 2003.
23. Brimmell M, Mendiola R, Mangion J, and Packham G: BAX frameshift mutations in cell lines derived from human haemopoietic malignancies are associated with resistance to apoptosis and microsatellite instability. Oncogene 16: 1803-1812, 1998.
24. Guchelaar HJ, Vermes I, Koopmans RP, Reutelingsperger CP and Haanen C: Apoptosis- and necrosis-inducing potential of cladribine, cytarabine, cisplatin, and 5-fluorouracil in vitro: a quantitative pharmacodynamic model. Cancer Chemother Pharmacol 42: 77-83, 1998.
25. Gruber C, Henkel M, Budach W, Belka C and Jendrossek V: Involvement of tyrosine kinase p56/Lck in apoptosis induction by anticancer drugs. Biocheml Pharmacol 67: 1859-1872, 2004.
26. Vermes I, Haanen C and Reutelingsperger C: Flow cytometry of apoptotic cell death. J Immunol Meth 243: 167-190, 2000.
27. van GH, Kenis H, Lux P, Ungeth L, Maassen C, Deckers N, Narula J, Hofstra L and Reutelingsperger C: In vitro measurement of cell death with the annexin A5 affinity assay. Nat Protoc 1: 363-367, 2006.
28. Bedner E, Li X, Gorczyca W, Melamed MR and Darzynkiewicz Z: Analysis of apoptosis by laser scanning cytometry. Cytometry 35: 181-195, 1999.
29. Kumar S: The apoptotic cysteine protease CPP32. Int J Biochem Cell Biol 29: 393-396, 1997.
30. Li X and Darzynkiewicz Z: Cleavage of poly(ADP-ribose) polymerase measured in situ in individual cells: relationship to DNA fragmentation and cell cycle position during apoptosis. Exp Cell Res 255: 125-132, 2000.
31. Soldani C and Scovassi AI: Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update. Apoptosis 7: 321-328, 2002.
32. Zamzami N, Maisse C, Metivier D and Kroemer G: Measurement of membrane permeability and the permeability transition of mitochondria. Meth Cell Biol 80: 327-340, 2007.
33. Castedo M, Ferri K, Roumier T, Metivier D, Zamzami N and Kroemer G: Quantitation of mitochondrial alterations associated with apoptosis. J Immunol Meth 265: 39-47, 2002.
34. Gogvadze V and Orrenius S: Mitochondrial regulation of apoptotic cell death. Chem Biol Inter 163: 4-14, 2006.
35. Gogvadze V, Orrenius S and Zhivotovsky B: Mitochondria in cancer cells: What is so special about them? Trends Cell Biol 18: 165-173, 2008.
36. Le GS, Podar K, Harousseau JL and Anderson KC: Mcl-1 regulation and its role in multiple myeloma. Cell Cycle 3: 1259-1262, 2004.
37. Michels J, Johnson PW and Packham G: Mcl-1. Int J Biochem Cell Biol 37: 267-271, 2005.
38. Warr MR and Shore GC: Unique biology of Mcl-1: therapeutic opportunities in cancer. Curr Mol Med 8: 138-147, 2008.
39. Vandenabeele P, Vanden BT and Festjens N: Caspase inhibitors promote alternative cell death pathways. Sci STKE 2006: e44, 2006.
40. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS, Golstein P, Green DR, Hengartner M, Knight RA, Kumar S, Lipton SA, Malorni W, Nunez G, Peter ME, Tschopp J, Yuan J, Piacentini M, Zhivotovsky B and Melino G: Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 16: 3-11, 2009.
41. 6 (3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells: implications for studies on mitochondrial functionality during apoptosis. FEBS Lett 411: 77-82, 1997.
42. Orrenius S, Gogvadze V and Zhivotovsky B: Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol Toxicol 47: 143-183, 2007.
43. Michels J, O'Neill JW, Dallman CL, Mouzakiti A, Habens F, Brimmell M, Zhang KY, Craig RW, Marcusson EG, Johnson PW and Packham G: Mcl-1 is required for Akata6 B-lymphoma cell survival and is converted to a cell death molecule by efficient caspase-mediated cleavage. Oncogene 23: 4818-4827, 2004.
44. Bae J, Leo CP, Hsu SY and Hsueh AJ: MCL-1S, a splicing variant of the antiapoptotic BCL-2 family member MCL-1, encodes a proapoptotic protein possessing only the BH3 domain. J Biol Chem 275: 25255-25261, 2000.
45. Bingle CD, Craig RW, Swales BM, Singleton V, Zhou P and Whyte MK: Exon skipping in Mcl-1 results in a bcl-2 homology domain 3 only gene product that promotes cell death. J Biol Chem 275: 22136-22146, 2000.